View in EDS HTML Full Text PDF Full Text

BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis.

Saved in:

Bibliographic Details
Title:	BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis.
Authors:	Fedele, Palma¹ (AUTHOR) palma.fedele@asl.brindisi.it, Rizzo, Alessandro² (AUTHOR), Landriscina, Matteo³ (AUTHOR), Stucci, Stefania Luigia⁴ (AUTHOR), Morritti, Maria⁵ (AUTHOR), Giuliani, Francesco⁶ (AUTHOR), Moraca, Lucia⁷ (AUTHOR), Cairo, Giuseppe⁸ (AUTHOR), Ardito, Raffaele⁹ (AUTHOR), Giampaglia, Marianna¹⁰ (AUTHOR), Bilancia, Domenico^10,11 (AUTHOR), Melaccio, Assunta^6,12 (AUTHOR), Terenzio, Antonella^1,3 (AUTHOR), Gnoni, Antonio^2,11 (AUTHOR), Licchetta, Antonella^3,11 (AUTHOR), Fumai, Federica^1,4 (AUTHOR), Lanotte, Laura^5,12 (AUTHOR), Gadaleta-Caldarola, Gennaro^6,12 (AUTHOR)
Source:	Journal of Clinical Medicine. Dec2025, Vol. 14 Issue 24, p8854. 10p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	20770383
DOI:	10.3390/jcm14248854